Image
The Earlham Institute (formerly The Genome Analysis Centre (TGAC)), like all research institutes in the UK, benefits from EU funding but also many of our research staff are non-British EU nationals. Therefore, we currently depend on free movement to maintain our scientific excellence and competitive edge.
The ramifications of this decision will depend very much on what will replace what we have now, and I sincerely hope that the Government value the UK’s leading position in research and do not hamstring us by restricting collaboration and cooperation across borders.
Currently, the UK continues to be a member of the EU and we will continue to deliver our normal business. We expect that over the coming weeks the Government will consider the details and timing of its current legislative programme as set out in the Queen’s speech, in light of the referendum result. We will be working with BBSRC and the other Research Councils to keep every one of our staff and collaborators as informed as possible.
Meanwhile, we are committed to continuing our research strategy and to remaining a world-class research institute. Our staff are key to our success as an institute and we hope to continue to attract and retain talented individuals from across the EU and beyond. The EI will continue to value and welcome all people of all nationalities.
Professor Neil Hall, Director of Earlham Institute
